Adjusting for underenumeration in the 1991 census.

Por Leese, M., Loftus, L., Thornicroft, G.
Publicado em 1995

Ethnic differences in risk of compulsory psychiatric admission among representative cases of psychosis in London.

Por Davies, S., Thornicroft, G., Leese, M., Higgingbotham, A., Phelan, M.
Publicado em 1996

Are investigations anxiolytic or anxiogenic? A randomised controlled trial of neuroimaging to provide reassurance in chronic daily headache

Por Howard, L, Wessely, S, Leese, M, Page, L, McCrone, P, Husain, K, Tong, J, Dowson, A
Publicado em 2005

Class III β-tubulin expression and in vitro resistance to microtubule targeting agents

Por Stengel, C, Newman, S P, Leese, M P, Potter, B V L, Reed, M J, Purohit, A
Publicado em 2010

In vivo inhibition of angiogenesis by sulphamoylated derivatives of 2-methoxyoestradiol

Por Chander, S K, Foster, P A, Leese, M P, Newman, S P, Potter, B V L, Purohit, A, Reed, M J
Publicado em 2007

2-Methoxyoestradiol-3,17-O,O-bis-sulphamate and 2-deoxy-D-glucose in combination: a potential treatment for breast and prostate cancer

Por Tagg, S L C, Foster, P A, Leese, M P, Potter, B V L, Reed, M J, Purohit, A, Newman, S P
Publicado em 2008

Randomized controlled trial of computerized cognitive behavioural therapy for depressive symptoms: effectiveness and costs of a workplace intervention

Por Phillips, R., Schneider, J., Molosankwe, I., Leese, M., Foroushani, P. Sarrami, Grime, P., McCrone, P., Morriss, R., Thornicroft, G.
Publicado em 2014

Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodents

Por Ireson, C R, Chander, S K, Purohit, A, Perera, S, Newman, S P, Parish, D, Leese, M P, Smith, A C, Potter, B V L, Reed, M J
Publicado em 2004

The in vivo properties of STX243: a potent angiogenesis inhibitor in breast cancer

Por Parsons, M F C, Foster, P A, Chander, S K, Jhalli, R, Newman, S P, Leese, M P, Potter, B V L, Purohit, A, Reed, M J
Publicado em 2008

BCRP expression does not result in resistance to STX140 in vivo, despite the increased expression of BCRP in A2780 cells in vitro after long-term STX140 exposure

Por Day, J M, Foster, P A, Tutill, H J, Newman, S P, Ho, Y T, Leese, M P, Potter, B V L, Reed, M J, Purohit, A
Publicado em 2009

The therapeutic potential of a series of orally bioavailable anti-angiogenic microtubule disruptors as therapy for hormone-independent prostate and breast cancers

Por Newman, S P, Foster, P A, Ho, Y T, Day, J M, Raobaikady, B, Kasprzyk, P G, Leese, M P, Potter, B V L, Reed, M J, Purohit, A
Publicado em 2007

In vivo and in vitro properties of STX2484: a novel non-steroidal anti-cancer compound active in taxane-resistant breast cancer

Por Stengel, C, Newman, S P, Day, J M, Chander, S K, Jourdan, F L, Leese, M P, Ferrandis, E, Regis-Lydi, S, Potter, B V L, Reed, M J, Purohit, A, Foster, P A
Publicado em 2014